Dominant Negative TRAF3 Variant With Recurrent Mycobacterium abscessus Infection and Bronchiectasis

Mei Fong Liew1, Hui Fang Lim2, Mui Cheng Liang3

  • 1FAST and Chronic Programmes, Alexandra Hospital, National University Health System, Singapore, Singapore.

Insights

Host factors for pulmonary nontuberculous mycobacteria (PNTM) disease remain unclear. This study identified a tumor necrosis factor receptor associated factor 3 (TRAF3) variant linked to recurrent PNTM infections, revealing TRAF3 and TNF-α deficiencies.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Pulmonary nontuberculous mycobacteria (PNTM) disease pathogenesis is poorly understood.
  • Disseminated nontuberculous mycobacteria (NTM) disease is associated with the interleukin-12/interferon-gamma (IL-12/IFN-γ) signaling pathway.
  • Host genetic factors influencing PNTM susceptibility require further investigation.

Purpose of the Study:

  • To investigate the role of the tumor necrosis factor receptor associated factor 3 (TRAF3) R338W variant in a patient with recurrent PNTM infection.
  • To elucidate the impact of this variant on immune function and susceptibility to PNTM.

Main Methods:

  • Genetic analysis of a patient with recurrent PNTM.
  • Ex vivo immune studies to assess cellular responses.
  • Cloning-transfection cellular studies to investigate protein function.

Main Results:

  • Identification of the TRAF3 R338W variant in the patient.
  • Demonstration of TRAF3-deficient and tumor necrosis factor-alpha (TNF-α)-deficient phenotypes.
  • Evidence linking the variant to impaired immune responses.

Conclusions:

  • The TRAF3 R338W variant may contribute to susceptibility to recurrent PNTM disease.
  • TRAF3 and TNF-α signaling are critical for host defense against PNTM.
  • Further research into genetic host factors is warranted for understanding PNTM pathogenesis.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
315
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
414
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
348
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
303
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
227
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
190